In patients with multivessel disease, complete revascularization (CR) is the most biologically plausible approach irrespective of definition or type or clinical setting (acute or chronic coronary syndrome [ACS or CCS]). It aims at minimizing residual ischemia, relieving symptoms and reducing the risk of future cardiovascular events. Large evidence supports CR benefits in ACS, predominantly ST-segment elevation myocardial infarction, except cardiogenic shock, although optimal assessment and timing remain debated. In patients with CCS, when revascularization is indicated, a functional CR should be attempted. Therefore, heart-team is crucial in selecting the ideal strategy for each patient to optimize decision-making.
Complete Revascularization in Acute and Chronic Coronary Syndrome / Ilardi, F.; Ferrone, M.; Avvedimento, M.; Servillo, G.; Gargiulo, G.. - In: CARDIOLOGY CLINICS. - ISSN 0733-8651. - 38:4(2020), pp. 491-505. [10.1016/j.ccl.2020.06.003]
Complete Revascularization in Acute and Chronic Coronary Syndrome
Ilardi F.
;Ferrone M.;Avvedimento M.;Servillo G.Writing – Original Draft Preparation
;Gargiulo G.
2020
Abstract
In patients with multivessel disease, complete revascularization (CR) is the most biologically plausible approach irrespective of definition or type or clinical setting (acute or chronic coronary syndrome [ACS or CCS]). It aims at minimizing residual ischemia, relieving symptoms and reducing the risk of future cardiovascular events. Large evidence supports CR benefits in ACS, predominantly ST-segment elevation myocardial infarction, except cardiogenic shock, although optimal assessment and timing remain debated. In patients with CCS, when revascularization is indicated, a functional CR should be attempted. Therefore, heart-team is crucial in selecting the ideal strategy for each patient to optimize decision-making.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
